Evidence map›Paper›PMID 40535956›Full record

ReviewRSC advances2025

Removal of pharmaceutical residues from aquatic systems using bimetallic metal-organic frameworks (BMOFs): a critical review.

Kawan F Kayani

Abstract readReview
In one paragraph

Review in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Kawan F KayaniDepartment of Chemistry, College of Science, University of Sulaimani Kurdistan 46001 Iraq kawan.nasralddin@univsul.edu.iq.ORCID https://orcid.org/0000-0003-1159-2147

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, pharmaceuticals have become a major environmental issue due to their ongoing release and persistence in aquatic ecosystems, even at low concentrations. Among various solutions, bimetallic metal-organic frameworks (BMOFs) have attracted considerable attention. This is not only because of their tunable pore structures, large surface area, and excellent reactivity but also due to the incorporation of multiple metal ions, which enhance their ability to remove and degrade pharmaceutical residues. This review provides a detailed analysis of the advantages of BMOFs, introduces the occurrence of pharmaceutical residues and their toxic effects on the environment and humans, and, for the first time, explores their applications in removing pharmaceutical residues. Additionally, we discuss current challenges and future perspectives for BMOFs, aiming to advance their development and maximize their potential in environmental applications. We aim to provide detailed and meaningful insights to researchers in both materials science and environmental studies, thereby driving advancement in this interdisciplinary arena.

Identifiers

PMID40535956
PMCPMC12174980

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.